Avelumab (MSB0010718C; anti-PD-L1) in patients with...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma progressed after platinum-based therapy or platinum ineligible

Patel, M.R., Ellerton, J., Agrawal, M., Gordon, M., Dirix, L., Lee, K-W., Infante, J., Schlichting, M., Chin, K., Apolo, A.B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw373.05
Date:
October, 2016
File:
PDF, 40 KB
english, 2016
Conversion to is in progress
Conversion to is failed